Kissei Pharmaceutical Co (TSE:4547) YoY EBITDA Growth : -19.22% (As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Kissei Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -19.22%.

Kissei Pharmaceutical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円80.17.

Kissei Pharmaceutical Co YoY EBITDA Growth Historical Data

The historical data trend for Kissei Pharmaceutical Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co YoY EBITDA Growth Chart

Kissei Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

-26.01

47.73

92.56

-12.10

7.12

Kissei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-39.81	103.26	39.27	-19.22	-25.54

Kissei Pharmaceutical Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Kissei Pharmaceutical Co's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(413.687	-	386.187)	/	\| 386.187 \|
=	7.12 %

Kissei Pharmaceutical Co's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(80.171	-	99.25)	/	\| 99.25 \|
=	-19.22 %

Kissei Pharmaceutical Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Kissei Pharmaceutical Co (TSE:4547) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

KSPHF:USA

Address

19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710

Website

http://www.kissei.co.jp

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines